Browse By: Country ι Category ι Publisher ι Tag
Home  »  Global Markets Direct

Global Markets Direct Market Research Reports

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

Emesis (Vomiting) - Pipeline Review, H2 2014
Global Markets Directs, Emesis (Vomiting) Pipeline Review, H2 2014, provides an overview of the Emesis (Vomiting)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Emesis (Vomiting), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Emesis (Vomiting) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Myasthenia Gravis - Pipeline Review, H2 2014
Global Markets Directs, Myasthenia Gravis Pipeline Review, H2 2014, provides an overview of the Myasthenia Graviss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myasthenia Gravis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Malignant Glioma - Pipeline Review, H2 2014
Global Markets Directs, Malignant Glioma Pipeline Review, H2 2014, provides an overview of the Malignant Gliomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Glioma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014
Global Markets Directs, Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Pipeline Review, H2 2014, provides an overview of the Transitional Cell Carcinoma (Urothelial Cell Carcinoma)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma) and special features on late-stage and discontinued projects. Global Market
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Retinal Degeneration - Pipeline Review, H2 2014
Global Markets Directs, Retinal Degeneration Pipeline Review, H2 2014, provides an overview of the Retinal Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Retinal Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinal Degeneration and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Restenosis - Pipeline Review, H2 2014
Global Markets Directs, Restenosis Pipeline Review, H2 2014, provides an overview of the Restenosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Restenosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Restenosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information source
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Tauopathies - Pipeline Review, H2 2014
Global Markets Directs, Tauopathies Pipeline Review, H2 2014, provides an overview of the Tauopathiess therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tauopathies, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tauopathies and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2014
Global Markets Directs, Nasopharyngitis (Common Cold) Pipeline Review, H2 2014, provides an overview of the Nasopharyngitis (Common Cold)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nasopharyngitis (Common Cold), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nasopharyngitis (Common Cold) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and n
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014
Global Markets Directs, Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Pipeline Review, H2 2014, provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) and special features on late-stage and discontinued projects. Globa
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014
Global Markets Directs, Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H2 2014, provides an overview of the Chemotherapy Induced Peripheral Neuropathys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Peripheral Neuropathy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Seasonal Allergic Rhinitis - Pipeline Review, H2 2014
Global Markets Directs, Seasonal Allergic Rhinitis Pipeline Review, H2 2014, provides an overview of the Seasonal Allergic Rhinitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Seasonal Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Seasonal Allergic Rhinitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Cedar Pollen Allergy - Pipeline Review, H2 2014
Global Markets Directs, Cedar Pollen Allergy Pipeline Review, H2 2014, provides an overview of the Cedar Pollen Allergys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cedar Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cedar Pollen Allergy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Sarcoidosis - Pipeline Review, H2 2014
Global Markets Directs, Sarcoidosis Pipeline Review, H2 2014, provides an overview of the Sarcoidosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sarcoidosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Plague - Pipeline Review, H2 2014
Global Markets Directs, Plague Pipeline Review, H2 2014, provides an overview of the Plagues therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plague and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Ma
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Periodontitis - Pipeline Review, H2 2014
Global Markets Directs, Periodontitis Pipeline Review, H2 2014, provides an overview of the Periodontitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Periodontitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Periodontitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Myotonic Dystrophy - Pipeline Review, H2 2014
Myotonic Dystrophy - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Myotonic Dystrophy - Pipeline Review, H2 2014, provides an overview of the Myotonic Dystrophys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myotonic Dystrophy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Intermittent Claudication - Pipeline Review, H2 2014
Intermittent Claudication - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Intermittent Claudication - Pipeline Review, H2 2014, provides an overview of the Intermittent Claudications therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Intermittent Claudication, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Intermittent Claudication and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Brain Injury - Pipeline Review, H2 2014
Brain Injury - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Brain Injury - Pipeline Review, H2 2014, provides an overview of the Brain Injurys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Injury and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Androgenic Alopecia - Pipeline Review, H2 2014
Androgenic Alopecia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Androgenic Alopecia - Pipeline Review, H2 2014, provides an overview of the Androgenic Alopecias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Androgenic Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Androgenic Alopecia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014, provides an overview of the Hospital Acquired Pneumonia (HAP)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hospital Acquired Pneumonia (HAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hospital Acquired Pneumonia (HAP) and special features on late-stage and discontinued projects.Global Markets Directs report features inves
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Pompe Disease - Pipeline Review, H2 2014
Pompe Disease - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Pompe Disease - Pipeline Review, H2 2014, provides an overview of the Pompe Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pompe Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pompe Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Rhinovirus Infection - Pipeline Review, H2 2014
Rhinovirus Infection - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Rhinovirus Infection - Pipeline Review, H2 2014, provides an overview of the Rhinovirus Infections therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Rhinovirus Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rhinovirus Infection and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Chronic Urticaria Or Hives - Pipeline Review, H2 2014
Chronic Urticaria Or Hives - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Chronic Urticaria Or Hives - Pipeline Review, H2 2014, provides an overview of the Chronic Urticaria Or Hivess therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Urticaria Or Hives, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Urticaria Or Hives and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014, provides an overview of the Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Methicillin-Suscept
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Bone Fracture - Pipeline Review, H2 2014
Bone Fracture - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Bone Fracture - Pipeline Review, H2 2014, provides an overview of the Bone Fractures therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Bone Fracture, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Fracture and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Hyperphosphatemia - Pipeline Review, H2 2014
Hyperphosphatemia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hyperphosphatemia - Pipeline Review, H2 2014, provides an overview of the Hyperphosphatemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hyperphosphatemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hyperphosphatemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Japan Tobacco Inc. - Product Pipeline Review - 2014
Global Markets Directs, Japan Tobacco Inc. Product Pipeline Review 2014, provides an overview of the Japan Tobacco Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Japan Tobacco Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourc
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Global Markets Directs, Kaken Pharmaceutical Co., Ltd. Product Pipeline Review 2014, provides an overview of the Kaken Pharmaceutical Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kaken Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bu
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2014
Global Markets Directs, D. Western Therapeutics Institute, Inc. Product Pipeline Review 2014, provides an overview of the D. Western Therapeutics Institute, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of D. Western Therapeutics Institute, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
PharmaEssentia Corporation - Product Pipeline Review - 2014
Global Markets Directs, PharmaEssentia Corporation Product Pipeline Review 2014, provides an overview of the PharmaEssentia Corporations pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of PharmaEssentia Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using da
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Creabilis SA - Product Pipeline Review - 2014
Global Markets Directs, Creabilis SA Product Pipeline Review 2014, provides an overview of the Creabilis SAs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Creabilis SAs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Mar
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
NovaBay Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, NovaBay Pharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the NovaBay Pharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NovaBay Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Bukwang Pharm.Co., Ltd. - Product Pipeline Review - 2014
Global Markets Directs, Bukwang Pharm.Co., Ltd. Product Pipeline Review 2014, provides an overview of the Bukwang Pharm.Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Bukwang Pharm.Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
High Point Pharmaceuticals, LLC - Product Pipeline Review - 2014
Global Markets Directs, High Point Pharmaceuticals, LLC Product Pipeline Review 2014, provides an overview of the High Point Pharmaceuticals, LLCs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of High Point Pharmaceuticals, LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
iCo Therapeutics Inc. - Product Pipeline Review - 2014
Global Markets Directs, iCo Therapeutics Inc. Product Pipeline Review 2014, provides an overview of the iCo Therapeutics Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of iCo Therapeutics Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Onyx Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, Onyx Pharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the Onyx Pharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Onyx Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using da
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014
Global Markets Directs, Shin Nippon Biomedical Laboratories, Ltd. Product Pipeline Review 2014, provides an overview of the Shin Nippon Biomedical Laboratories, Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Shin Nippon Biomedical Laboratories, Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
ASKA Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Global Markets Directs, ASKA Pharmaceutical Co., Ltd. Product Pipeline Review 2014, provides an overview of the ASKA Pharmaceutical Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ASKA Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usi
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2014
Global Markets Directs, Vanda Pharmaceuticals Inc. Product Pipeline Review 2014, provides an overview of the Vanda Pharmaceuticals Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vanda Pharmaceuticals Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, RegeneRx Biopharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the RegeneRx Biopharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of RegeneRx Biopharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The rep
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
biOasis Technologies Inc. - Product Pipeline Review - 2014
Global Markets Directs, biOasis Technologies Inc. Product Pipeline Review 2014, provides an overview of the biOasis Technologies Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of biOasis Technologies Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Redbiotec AG - Product Pipeline Review - 2014
Global Markets Directs, Redbiotec AG Product Pipeline Review 2014, provides an overview of the Redbiotec AGs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Redbiotec AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Mar
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Can-Fite BioPharma Ltd. - Product Pipeline Review - 2014
Global Markets Directs, Can-Fite BioPharma Ltd. Product Pipeline Review 2014, provides an overview of the Can-Fite BioPharma Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Can-Fite BioPharma Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Adienne Pharma & Biotech - Product Pipeline Review - 2014
Global Markets Directs, Adienne Pharma & Biotech Product Pipeline Review 2014, provides an overview of the Adienne Pharma & Biotechs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Adienne Pharma & Biotechs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Scancell Holdings Plc - Product Pipeline Review - 2014
Global Markets Directs, Scancell Holdings Plc Product Pipeline Review 2014, provides an overview of the Scancell Holdings Plcs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Scancell Holdings Plcs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Auspex Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, Auspex Pharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the Auspex Pharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Auspex Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
BioApex, s.r.o. - Product Pipeline Review - 2014
BioApex, s.r.o. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, BioApex, s.r.o. - Product Pipeline Review - 2014, provides an overview of the BioApex, s.r.o.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of BioApex, s.r.o.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Blueprint Medicines - Product Pipeline Review - 2014
Blueprint Medicines - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Blueprint Medicines - Product Pipeline Review - 2014, provides an overview of the Blueprint Mediciness pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Blueprint Mediciness, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Cerecor Inc. - Product Pipeline Review - 2014
Cerecor Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Cerecor Inc. - Product Pipeline Review - 2014, provides an overview of the Cerecor Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Cerecor Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014
Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014, provides an overview of the Grupo Ferrer Internacional, S.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Grupo Ferrer Internacional, S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe coverin
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Immune Design Corp. - Product Pipeline Review - 2014
Immune Design Corp. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Immune Design Corp. - Product Pipeline Review - 2014, provides an overview of the Immune Design Corp.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Design Corp.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Kite Pharma, Inc. - Product Pipeline Review - 2014
Kite Pharma, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Kite Pharma, Inc. - Product Pipeline Review - 2014, provides an overview of the Kite Pharma, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Kite Pharma, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The re
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
OncoSec Medical Inc. - Product Pipeline Review - 2014
OncoSec Medical Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, OncoSec Medical Inc. - Product Pipeline Review - 2014, provides an overview of the OncoSec Medical Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of OncoSec Medical Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014
Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014, provides an overview of the Panmira Pharmaceuticals, LLC.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Panmira Pharmaceuticals, LLC.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Phosphagenics Limited - Product Pipeline Review - 2014
Phosphagenics Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Phosphagenics Limited - Product Pipeline Review - 2014, provides an overview of the Phosphagenics Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Phosphagenics Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
RAPID Pharmaceuticals AG - Product Pipeline Review - 2014
RAPID Pharmaceuticals AG - Product Pipeline Review - 2014SummaryGlobal Markets Directs, RAPID Pharmaceuticals AG - Product Pipeline Review - 2014, provides an overview of the RAPID Pharmaceuticals AGs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of RAPID Pharmaceuticals AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and near
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Rodos BioTarget GmbH - Product Pipeline Review - 2014
Rodos BioTarget GmbH - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Rodos BioTarget GmbH - Product Pipeline Review - 2014, provides an overview of the Rodos BioTarget GmbHs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Rodos BioTarget GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Biosidus S.A. - Product Pipeline Review - 2014
Biosidus S.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Biosidus S.A. - Product Pipeline Review - 2014, provides an overview of the Biosidus S.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Biosidus S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Piramal Enterprises Limited - Product Pipeline Review - 2014
Piramal Enterprises Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Piramal Enterprises Limited - Product Pipeline Review - 2014, provides an overview of the Piramal Enterprises Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Piramal Enterprises Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
ReGenX Biosciences, LLC - Product Pipeline Review - 2014
ReGenX Biosciences, LLC - Product Pipeline Review - 2014SummaryGlobal Markets Directs, ReGenX Biosciences, LLC - Product Pipeline Review - 2014, provides an overview of the ReGenX Biosciences, LLCs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of ReGenX Biosciences, LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
PharmaIN Corporation - Product Pipeline Review - 2014
PharmaIN Corporation - Product Pipeline Review - 2014SummaryGlobal Markets Directs, PharmaIN Corporation - Product Pipeline Review - 2014, provides an overview of the PharmaIN Corporations pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of PharmaIN Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Teijin Pharma Limited - Product Pipeline Review - 2014
Teijin Pharma Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Teijin Pharma Limited - Product Pipeline Review - 2014, provides an overview of the Teijin Pharma Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Teijin Pharma Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Recordati S.p.A. - Product Pipeline Review - 2014
Recordati S.p.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Recordati S.p.A. - Product Pipeline Review - 2014, provides an overview of the Recordati S.p.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Recordati S.p.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Hemorrhagic Fever - Pipeline Review, H2 2014
Hemorrhagic Fever - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hemorrhagic Fever - Pipeline Review, H2 2014, provides an overview of the Hemorrhagic Fevers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hemorrhagic Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemorrhagic Fever and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) and special features on late-stage and discon
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Metastatic Breast Cancer - Pipeline Review, H2 2014
Metastatic Breast Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Metastatic Breast Cancer - Pipeline Review, H2 2014, provides an overview of the Metastatic Breast Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Metastatic Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Breast Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering o
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014
H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014, provides an overview of the H5N1 Infection (Avian Influenza)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for H5N1 Infection (Avian Influenza), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for H5N1 Infection (Avian Influenza) and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Anxiety Disorders - Pipeline Review, H2 2014
Anxiety Disorders - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Anxiety Disorders - Pipeline Review, H2 2014, provides an overview of the Anxiety Disorderss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anxiety Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anxiety Disorders and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Allergic Asthma - Pipeline Review, H2 2014
Allergic Asthma - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Allergic Asthma - Pipeline Review, H2 2014, provides an overview of the Allergic Asthmas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Allergic Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Asthma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Anthrax - Pipeline Review, H2 2014
Anthrax - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Anthrax - Pipeline Review, H2 2014, provides an overview of the Anthraxs therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anthrax, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anthrax and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014, provides an overview of the Wet (Neovascular / Exudative) Macular Degenerations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration and special features
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Esophageal Cancer - Pipeline Review, H2 2014
Esophageal Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Esophageal Cancer - Pipeline Review, H2 2014, provides an overview of the Esophageal Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Esophageal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Esophageal Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Dementia - Pipeline Review, H2 2014
Dementia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Dementia - Pipeline Review, H2 2014, provides an overview of the Dementias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dementia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Post-Operative Pain - Pipeline Review, H2 2014
Post-Operative Pain - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Post-Operative Pain - Pipeline Review, H2 2014, provides an overview of the Post-Operative Pains therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Post-Operative Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Operative Pain and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014, provides an overview of the Retinitis Pigmentosa (Retinitis)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinitis Pigmentosa (Retinitis) and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Recurrent Glioblastoma Multiforme (GBM), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Recurrent Glioblastoma Multiforme (GBM) and special features on late-stage and discontinued projects.Global Markets
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014, provides an overview of the Chemotherapy Induced Neutropenias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Neutropenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Neutropenia and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Critical Limb Ischemia - Pipeline Review, H2 2014
Critical Limb Ischemia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Critical Limb Ischemia - Pipeline Review, H2 2014, provides an overview of the Critical Limb Ischemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Critical Limb Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Critical Limb Ischemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Thyroid Cancer - Pipeline Review, H2 2014
Thyroid Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Thyroid Cancer - Pipeline Review, H2 2014, provides an overview of the Thyroid Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thyroid Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014
Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014, provides an overview of the Allergic Rhino-Conjunctivitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Allergic Rhino-Conjunctivitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhino-Conjunctivitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014
Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014, provides an overview of the Dry (Atrophic) Macular Degenerations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Dry (Atrophic) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dry (Atrophic) Macular Degeneration and special features on late-stage and discontinued projects.Global Markets Directs report feat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Seizures - Pipeline Review, H2 2014
Seizures - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Seizures - Pipeline Review, H2 2014, provides an overview of the Seizuress therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Seizures, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Seizures and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Fragile X Syndrome - Pipeline Review, H2 2014
Fragile X Syndrome - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Fragile X Syndrome - Pipeline Review, H2 2014, provides an overview of the Fragile X Syndromes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Fragile X Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fragile X Syndrome and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2014
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2014, provides an overview of the Chemotherapy Induced Nausea and Vomitings therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Nausea and Vomiting, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Nausea and Vomiting and special features on late-stage and discontinued projects.Global Ma
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2014
Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2014, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junctions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Adenocarcinoma Of The Gastroesophageal Junction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Adenocarcinoma Of The Gastroesophageal Junction and special features on late-stage
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Hepatic (Liver) Metastasis - Pipeline Review, H2 2014
Hepatic (Liver) Metastasis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hepatic (Liver) Metastasis - Pipeline Review, H2 2014, provides an overview of the Hepatic (Liver) Metastasiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hepatic (Liver) Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatic (Liver) Metastasis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Reperfusion Injury - Pipeline Review, H2 2014
Reperfusion Injury - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Reperfusion Injury - Pipeline Review, H2 2014, provides an overview of the Reperfusion Injurys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Reperfusion Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Reperfusion Injury and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cognitive Impairment Associated With Schizo
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Hearing Disorders - Pipeline Review, H2 2014
Hearing Disorders - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hearing Disorders - Pipeline Review, H2 2014, provides an overview of the Hearing Disorderss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hearing Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hearing Disorders and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Gaucher's Disease - Pipeline Review, H2 2014
Gaucher's Disease - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Gaucher's Disease - Pipeline Review, H2 2014, provides an overview of the Gaucher's Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Gaucher's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gaucher's Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Degenerative Disc Disease - Pipeline Review, H2 2014
Degenerative Disc Disease - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Degenerative Disc Disease - Pipeline Review, H2 2014, provides an overview of the Degenerative Disc Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Degenerative Disc Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Degenerative Disc Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2014
Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2014, provides an overview of the Alpha- Antitrypsin Deficiencys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Alpha- Antitrypsin Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alpha- Antitrypsin Deficiency and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Thalassemia - Pipeline Review, H2 2014
Thalassemia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Thalassemia - Pipeline Review, H2 2014, provides an overview of the Thalassemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thalassemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thalassemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Nicotine Addiction - Pipeline Review, H2 2014
Nicotine Addiction - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Nicotine Addiction - Pipeline Review, H2 2014, provides an overview of the Nicotine Addictions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Nicotine Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nicotine Addiction and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Xiber Science GmbH - Product Pipeline Review - 2014
Xiber Science GmbH - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Xiber Science GmbH - Product Pipeline Review - 2014, provides an overview of the Xiber Science GmbHs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Xiber Science GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Th
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500
XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2014
XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2014, provides an overview of the XTL Biopharmaceuticals Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of XTL Biopharmaceuticals Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500
Zensun (Shanghai) Sci & Tech Co., Ltd. - Product Pipeline Review - 2014
Zensun (Shanghai) Sci & Tech Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Zensun (Shanghai) Sci & Tech Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the Zensun (Shanghai) Sci & Tech Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Zensun (Shanghai) Sci & Tech Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs f
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500
Ziarco Pharma Ltd - Product Pipeline Review - 2014
Ziarco Pharma Ltd - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Ziarco Pharma Ltd - Product Pipeline Review - 2014, provides an overview of the Ziarco Pharma Ltds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Ziarco Pharma Ltds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The re
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500
Daiichi Sankyo Company, Limited - Product Pipeline Review - 2014
Daiichi Sankyo Company, Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Daiichi Sankyo Company, Limited - Product Pipeline Review - 2014, provides an overview of the Daiichi Sankyo Company, Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Daiichi Sankyo Company, Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering ov
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500
Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014
Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014, provides an overview of the Hisamitsu Pharmaceutical Co., Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Hisamitsu Pharmaceutical Co., Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $1500